Format

Send to

Choose Destination
Pediatr Dermatol. 2019 Nov;36(6):986-987. doi: 10.1111/pde.14003. Epub 2019 Oct 6.

Severe recurrent aphthous stomatitis treated with adalimumab: A case report in a teenage patient.

Author information

1
Department of Dermatology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
2
Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

Abstract

Recurrent aphthous stomatitis (RAS) is a chronic disorder of unknown etiology characterized by recurring ulcers involving the oral mucosa in patients with no other manifestations. It is a common cause of oral ulcers in children. In its major form, RAS can be a severe and disabling disorder due to pain and scarring, and poses a therapeutic challenge. Therapies for major RAS include prednisone, thalidomide, colchicine, and dapsone. However, many patients do not achieve adequate control of the disease with them (J Clin Diagn Res, 10, 2016 and ZE08). We report a case of severe RAS in a teenager with a dramatic response to adalimumab.

KEYWORDS:

RAS; TNF-α; adalimumab; anti-TNF; aphthous stomatitis

PMID:
31588588
DOI:
10.1111/pde.14003

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center